Perioperative outcomes of neoadjuvant immunotherapy plus chemotherapy and neoadjuvant chemoradiotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective comparative cohort study

BACKGROUND: Neoadjuvant chemoradiotherapy (nCRT) is recommended as the preferred treatment for locally advanced esophageal squamous cell carcinoma. Recent studies have shown that immune checkpoint inhibitors are beneficial in treating advanced esophageal cancer. Therefore, a growing number of clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hai, Zhang, Zhenyang, Yang, Litao, Wu, Bomeng, Chen, Ying, He, Haiquan, Li, Cui, Lin, Wanli, Lin, Jiangbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089853/
https://www.ncbi.nlm.nih.gov/pubmed/37065590
http://dx.doi.org/10.21037/jtd-23-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089853/
https://www.ncbi.nlm.nih.gov/pubmed/37065590
http://dx.doi.org/10.21037/jtd-23-84

Ejemplares similares